Matthew A.T. Croco - Concepedia

Author

Matthew A.T. Croco

University of Iowa

Also Known As

M. A. T. Croco, M. Croco, M.A.T. Croco, Matthew A.T Croco, Matthew A.T. Croco

Publications

213

Citations

H-Index

Concepts

All Affiliations

University of Iowa

About

Matthew A.T. Croco is an author at University of Iowa specializing in medicine, antimicrobial resistance, and clinical microbiology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	6	6	198
2	Microbiology	4	4	99
3	Health Sciences	1	1	22
4	Epidemiology	1	1	62
5	Pathology	1	1	37

Matthew A.T. Croco

Publications

198

Citations

H-Index

Page 1

	Year	Citations
Respiratory tract pathogens isolated from patients hospitalized with suspected pneumonia: frequency of occurrence and antimicrobial susceptibility patterns from the SENTRY Antimicrobial Surveillance Program (United States and Canada, 1997) Ronald N. Jones, Matthew A.T. Croco, Kari C. Kugler, Diagnostic Microbiology and Infectious Disease AntibioticsSuspected PneumoniaRespiratory DiseasesMedicineHealthcare-associated Infection	2000	62
In vitro evaluation of a novel orally administered cephalosporin (cefditoren) tested against 1249 recent clinical isolates of Haemophilus influenzae, Moraxella catarrhalis, and Streptococcus pneumoniae Ronald N. Jones, Douglas J. Biedenbach, Matthew A.T. Croco, Diagnostic Microbiology and Infectious Disease Streptococcus PneumoniaeAntimicrobial SusceptibilityKlebsiella PneumoniaeClinical InfectionRecent Clinical Isolates	1998	46
BAY 12-8039, a novel fluoroquinolone Douglas J. Biedenbach, Mary S. Barrett, Matthew A.T. Croco, Diagnostic Microbiology and Infectious Disease Bay 12-8039Medicinal ChemistryMedicinePathologyFluorous Synthesis	1998	37
Antimicrobial activity evaluations of gatifloxacin, a new fluoroquinolone: contemporary pathogen results from a global antimicrobial resistance surveillance program (SENTRY, 1997) Ronald N. Jones, Matthew A.T. Croco, Michael A. Pfaller, Clinical Microbiology and Infection Antimicrobial SusceptibilityHealth SciencesAntibioticsMedicineContemporary Pathogen Results	1999	22
Comparative In Vitro Activity of Gatifloxacin Against Stenotrophomonas maltophilia and Burkholderia Species Isolates Including Evaluation of Disk Diffusion and E Test Methods Douglas J. Biedenbach, Matthew A.T. Croco, Timothy J. Barrett, European Journal of Clinical Microbiology & Infectious Diseases Antifungal AgentAntimicrobial SusceptibilityDisk DiffusionE Test MethodsAntimicrobial Chemotherapy	1999	21
Comparative in vitro evaluation of dirithromycin tested against recent clinical isolates of Haemophilus influenzae, moraxella catarrhalis, and streptococcus pneumoniae, including effects of medium supplements and test conditions on MIC results Douglas J. Biedenbach, Ronald N. Jones, M.Todd Lewis, Diagnostic Microbiology and Infectious Disease Antimicrobial SusceptibilityAntibioticsAntimicrobial StewardshipKlebsiella PneumoniaeRecent Clinical Isolates	1999	10

Page 1